AC Immune Presents First In vivo Images of Brain TDP-43 Pathology from Phase 1 Trial of PET tracer ACI-19626, at AD/PDTM 2026

Go back to AC Immune Presents First In vivo Images of Brain TDP-43 Pathology from Phase 1 Trial of PET tracer ACI-19626, at AD/PDTM 2026
(NASDAQ: ACIU) Delayed: 2.51 --0 (-0%)
Previous Close $2.51    52 Week High $19.97 
Open $2.51    52 Week Low $10.36 
Day High $2.51    P/E N/A 
Day Low $2.51    EPS $0.00 
Volume